Showing results (301-310 of 328) with videos related to

Sort By:
Pageof 33
The New England Journal of Medicine|March 21, 2017
Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac SurgeryRajendra H Mehta, Jeffrey D Leimberger, Sean van Diepen, et al.
Circulation|December 17, 2019
Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory IssuesJaved Butler, Milton Packer, Stephen J Greene, et al.
JAMA|November 7, 2018
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical TrialBarry A Borlaug, Kevin J Anstrom, Gregory D Lewis, et al.
The New England Journal of Medicine|November 8, 2012
Ultrafiltration in decompensated heart failure with cardiorenal syndromeBradley A Bart, Steven R Goldsmith, Kerry L Lee, et al.
The New England Journal of Medicine|March 4, 2011
Diuretic strategies in patients with acute decompensated heart failureG Michael Felker, Kerry L Lee, David A Bull, et al.
American Heart Journal|March 5, 2013
TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research ConsortiumConnie N Hess, Sunil V Rao, David F Kong, et al.
Circulation|May 20, 2015
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) StudyMichael M Givertz, Kevin J Anstrom, Margaret M Redfield, et al.
Contemporary Clinical Trials|August 9, 2021
Design of the Healthcare Worker Exposure Response and Outcomes (HERO) research platformAnne Friedland, Adrian F Hernandez, Kevin J Anstrom, et al.
European Journal of Heart Failure|September 29, 2025
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trialRobert J Mentz, Javed Butler, Ciaran J McMullan, et al.
American Journal of Respiratory and Critical Care Medicine|January 1, 2021
Informing Healthcare Decisions with Observational Research Assessing Causal Effect. An Official American Thoracic Society Research StatementAndrea S Gershon, Peter K Lindenauer, Kevin C Wilson, et al.
Pageof 33